These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 38893542)

  • 1. Imidazopyridine Family: Versatile and Promising Heterocyclic Skeletons for Different Applications.
    Volpi G; Laurenti E; Rabezzana R
    Molecules; 2024 Jun; 29(11):. PubMed ID: 38893542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the Development of Imidazopyridine-Based Fluorescent Probes for Diverse Applications.
    Chaudhran PA; Sharma A
    Crit Rev Anal Chem; 2024; 54(7):2148-2165. PubMed ID: 36562726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.
    Garrido A; Vera G; Delaye PO; Enguehard-Gueiffier C
    Eur J Med Chem; 2021 Dec; 226():113867. PubMed ID: 34607244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.
    Krause M; Foks H; Gobis K
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28273868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.
    Vanda D; Zajdel P; Soural M
    Eur J Med Chem; 2019 Nov; 181():111569. PubMed ID: 31404862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pd-catalyzed annulation of imidazo[1,2-
    Semwal R; Badhani G; Adimurthy S
    Chem Commun (Camb); 2022 Feb; 58(10):1585-1588. PubMed ID: 35018924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions of aromatic N-heterocycles with d0fn-metal alkyl complexes supported by chelating diamide ligands.
    Diaconescu PL
    Acc Chem Res; 2010 Oct; 43(10):1352-63. PubMed ID: 20954750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The position of imidazopyridine and metabolic activation are pivotal factors in the antimutagenic activity of novel imidazo[1,2-a]pyridine derivatives.
    El-Sayed WM; Hussin WA; Al-Faiyz YS; Ismail MA
    Eur J Pharmacol; 2013 Sep; 715(1-3):212-8. PubMed ID: 23747653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review.
    Peytam F; Emamgholipour Z; Mousavi A; Moradi M; Foroumadi R; Firoozpour L; Divsalar F; Safavi M; Foroumadi A
    Bioorg Chem; 2023 Nov; 140():106831. PubMed ID: 37683538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of 1,3-thiazole analogues of imidazopyridines as potent positive allosteric modulators of GABA
    Tikhonova TA; Rassokhina IV; Kondrakhin EA; Fedosov MA; Bukanova JV; Rossokhin AV; Sharonova IN; Kovalev GI; Zavarzin IV; Volkova YA
    Bioorg Chem; 2020 Jan; 94():103334. PubMed ID: 31711764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity-Oriented Synthesis toward Aryl- and Phosphoryl-Functionalized Imidazo[1,2-
    Gernet A; Sevrain N; Volle JN; Ayad T; Pirat JL; Virieux D
    J Org Chem; 2020 Nov; 85(22):14730-14743. PubMed ID: 33166470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave assisted synthesis of bis and tris(ω-bromoacetophenones): versatile precursors for novel bis(imidazo[1,2-a]pyridines), bis(imidazo[1,2-a]pyrimidines) and their tris-analogs.
    Shaaban MR
    Chem Cent J; 2013 Jun; 7(1):105. PubMed ID: 23782550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances.
    Khatun S; Singh A; Bader GN; Sofi FA
    J Biomol Struct Dyn; 2022; 40(24):14279-14302. PubMed ID: 34779710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-Dimensional and Two-Dimensional Zn(II) Coordination Polymers with Ditopic Imidazo[1,5-
    Sozzi M; Chierotti MR; Gobetto R; Gomila RM; Marzaroli V; Priola E; Volpi G; Zago S; Frontera A; Garino C
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of imidazo[1,2-a]pyridines: a decade update.
    Bagdi AK; Santra S; Monir K; Hajra A
    Chem Commun (Camb); 2015 Jan; 51(9):1555-75. PubMed ID: 25407981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
    Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
    Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Review on the Therapeutic Versatility of Imidazo [2,1-b]thiazoles.
    Shareef MA; Khan I; Babu BN; Kamal A
    Curr Med Chem; 2020; 27(40):6864-6887. PubMed ID: 31362648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazopyridines as a source of biological activity and their pharmacological potentials-Infrared and Raman spectroscopic evidence of their content in pharmaceuticals and plant materials.
    Dymińska L
    Bioorg Med Chem; 2015 Sep; 23(18):6087-99. PubMed ID: 26314922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemical Oxidative C3 Acyloxylation of Imidazo[1,2-
    Yuan Y; Zhou Z; Zhang L; Li LS; Lei A
    Org Lett; 2021 Aug; 23(15):5932-5936. PubMed ID: 34296890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and anti-HBV activity evaluation of new substituted imidazo[4,5-b]pyridines.
    Gerasi M; Frakolaki E; Papadakis G; Chalari A; Lougiakis N; Marakos P; Pouli N; Vassilaki N
    Bioorg Chem; 2020 May; 98():103580. PubMed ID: 32005482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.